Keryx Biopharmaceuticals, Inc. (KERX) Trading at $4.63 Forms Bearish Double Bottom

May 3, 2018 - By Maria Fierro

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) Corporate Logo

During 2017 Q4 the big money sentiment decreased to 1.02. That’s change of 0.48, from 2017Q3’s 1.5. 20 investors sold all, 32 reduced holdings as Keryx Biopharmaceuticals, Inc. ratio dived. 33 grew positions while 20 funds took positions. Funds hold 74.81 million shares thus 1.05% less from 2017Q3’s 75.60 million shares.
129,913 were reported by Group One Trading L P. Deltec Asset Mngmt Lc invested in 0.02% or 20,000 shs. Usca Ria Limited Liability Co reported 0.01% in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). 90,715 were reported by Janney Montgomery Scott Ltd Liability Corp. Abrams Cap Mngmt Lp, Massachusetts-based fund reported 9.72M shs. 943,863 were accumulated by Bancorp Of New York Mellon Corp. State Board Of Administration Of Florida Retirement System stated it has 0% of its capital in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). American International Group invested 0% of its capital in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Integral Derivatives Limited Liability has 11,627 shs for 0% of their capital. Marco Investment Limited Liability Corporation reported 0.04% in Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX). Vanguard owns 7.89M shs. Blair William & Il, a Illinois-based fund reported 188,100 shs. Jpmorgan Chase & owns 21,769 shs. Legal & General Grp Public invested in 31,209 shs. Manufacturers Life Insur The accumulated 75,179 shs.

Keryx Biopharmaceuticals, Inc. had 15 insider sales and 0 buys since January 5, 2018. This’s net activity of $275,021. Neylan John F. also sold $6,504 worth of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) shs. On Monday, January 29 $13,612 worth of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) was sold by Holmes Scott A. $5,004 worth of stock was sold by Madison Greg on Friday, January 5. On Thursday, January 18 Carberry Christine A. sold $44,064 worth of Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) or 9,048 shs.

The double bottom chart setup of Keryx Biopharmaceuticals, Inc. (KERX) has $4.21 Target or 9.00 % below today’s $4.63 share price. Keryx Biopharmaceuticals, Inc. (KERX) has $551.19 million MC. Finviz.com reported this chart setup on May, 3. The valuation of KERX can change by $49.61M if our $4.21 Target is hit.

KERX is reaching $4.625 during the last trading session, after decreased 3.24%.Currently Keryx Biopharmaceuticals, Inc. is downtrending after 32.44% change in last May 3, 2017. KERX has also 163,726 shares volume. KERX underperformed by 43.99% the S&P500.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) Ratings Coverage

Total analysts of 2 have positions in Keryx Biopharmaceuticals (NASDAQ:KERX) as follows: 0 rated it a “Buy”, 0 with “Sell” and 2 with “Hold”. The positive are 0. Since November 8, 2017 according to StockzIntelligence Inc Keryx Biopharmaceuticals has 2 analyst reports. The company rating was maintained by Stifel Nicolaus on Wednesday, November 8. In Thursday, February 8 report Morgan Stanley maintained the stock with “Equal-Weight” rating.

Keryx Biopharmaceuticals, Inc. (NASDAQ:KERX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: